CEL-SCI Corp. (CVM)
1.62
+0.01
(+0.62%)
USD |
NYAM |
Aug 27, 16:00
1.62
0.00 (0.00%)
After-Hours: 16:40
CEL-SCI Shareholders Equity (Quarterly) : 10.96M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.96M |
| March 31, 2026 | 6.875M |
| December 31, 2025 | 11.14M |
| September 30, 2025 | 15.96M |
| June 30, 2025 | 7.025M |
| March 31, 2025 | 7.998M |
| December 31, 2024 | 11.31M |
| September 30, 2024 | 12.87M |
| June 30, 2024 | 8.473M |
| March 31, 2024 | 14.30M |
| December 31, 2023 | 12.65M |
| September 30, 2023 | 13.21M |
| June 30, 2023 | 14.79M |
| March 31, 2023 | 20.15M |
| December 31, 2022 | 26.59M |
| September 30, 2022 | 32.16M |
| June 30, 2022 | 38.73M |
| March 31, 2022 | 45.13M |
| December 31, 2021 | 51.35M |
| September 30, 2021 | 56.53M |
| June 30, 2021 | 59.79M |
| March 31, 2021 | 29.33M |
| December 31, 2020 | 28.84M |
| September 30, 2020 | 19.73M |
| June 30, 2020 | 20.89M |
| Date | Value |
|---|---|
| March 31, 2020 | 14.14M |
| December 31, 2019 | 8.954M |
| September 30, 2019 | 5.134M |
| June 30, 2019 | 1.146M |
| March 31, 2019 | 0.9555M |
| December 31, 2018 | 2.708M |
| September 30, 2018 | 0.0009M |
| June 30, 2018 | -1.252M |
| March 31, 2018 | -3.058M |
| December 31, 2017 | -4.834M |
| September 30, 2017 | -3.337M |
| June 30, 2017 | -5.084M |
| March 31, 2017 | -2.832M |
| December 31, 2016 | 4.694M |
| September 30, 2016 | -0.6792M |
| June 30, 2016 | -3.774M |
| March 31, 2016 | -2.939M |
| December 31, 2015 | 3.532M |
| September 30, 2015 | -5.230M |
| June 30, 2015 | 3.927M |
| March 31, 2015 | 0.3431M |
| December 31, 2014 | 11.84M |
| September 30, 2014 | 10.44M |
| June 30, 2014 | 15.04M |
| March 31, 2014 | 7.356M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agenus, Inc. | -199.08M |
| Amgen, Inc. | 11.69B |
| Anika Therapeutics, Inc. | 137.28M |
| BioCryst Pharmaceuticals, Inc. | -454.29M |
| Imunon, Inc. | 4.189M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 21.36M |
| Total Liabilities (Quarterly) | 10.40M |
| Debt to Equity Ratio | 0.721 |
| Current Ratio | 1.477 |
| Net Debt Paydown Yield | 2.88% |